Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis
- Autores
- Altcheh, Jaime Marcelo; Carosella, Mabel V.; Ceballos, Ana; D'Andrea, Ulises; Jofre, Sandra M.; Marotta, Carolina; Mugeri, Domingo; Sabbaj, Liliana; Soto, Adriana; Josse, Constant; Montestruc, Francois; McFarland, Lynne V.
- Año de publicación
- 2022
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: The choice of an appropriate probiotic for pediatric acute gastroenteritis (PAGE) can be confusing. Our aim was to compare the efficacy and safety of 2 probiotics (Saccharomyces boulardii CNCM I-745 vs a 4-strain mixture of Bacillus clausii O/C, SIN, N/R, T) for the treatment of PAGE. Methods: A 2-arm parallel, randomized trial recruited children (6 months to 5 years old) with mild-moderate acute diarrhea, from 8 centers in Argentina. A total of 317 children were enrolled and blindly randomized to 5 days of either S boulardii CNCM I-745 (n = 159) or a 4-strain mixture of B clausii (n = 158), then followed for 7 days post-probiotic treatment. A stool sample was collected at inclusion for pathogen identification. The primary outcome was duration of diarrhea defined as the time from enrollment to the last loose stool followed by the first 24-hour period with stool consistency improvement. Secondary outcomes included frequency of loose stools/day, severity of diarrhea, number reporting no diarrhea at Day 6, time-to-first formed stool, recurrence of diarrhea by study end (Day 12) and safety outcomes. Results: Three hundred twelve (98%) children completed the study. S boulardii CNCM I-745 showed a significant reduction (P =.04) in the mean duration of diarrhea (64.6 hours, 95% confidence interval [CI] 56.5-72.8) compared to those given B clausii (78.0 hours, 95% CI 69.9-86.1). Both probiotics showed improvement in secondary outcomes and were well-tolerated. Conclusion: In this study, S boulardii CNCM I-745 demonstrated better efficacy than B clausii mix for reducing the duration of pediatric acute diarrhea.
Fil: Altcheh, Jaime Marcelo. Gobierno de la Ciudad de Buenos Aires. Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas; Argentina
Fil: Carosella, Mabel V.. No especifíca;
Fil: Ceballos, Ana. Instituto Médico Río Cuarto; Argentina
Fil: D'Andrea, Ulises. Instituto Médico Río Cuarto; Argentina
Fil: Jofre, Sandra M.. No especifíca;
Fil: Marotta, Carolina. No especifíca;
Fil: Mugeri, Domingo. No especifíca;
Fil: Sabbaj, Liliana. No especifíca;
Fil: Soto, Adriana. No especifíca;
Fil: Josse, Constant. No especifíca;
Fil: Montestruc, Francois. No especifíca;
Fil: McFarland, Lynne V.. No especifíca; - Materia
-
BACILLUS CLAUSII
DIARRHEA
GASTROENTERITIS
PROBIOTICS
SACCHAROMYCES BOULARDII - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/201388
Ver los metadatos del registro completo
id |
CONICETDig_172242ceec533ebaec8380b9a0ab287f |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/201388 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritisAltcheh, Jaime MarceloCarosella, Mabel V.Ceballos, AnaD'Andrea, UlisesJofre, Sandra M.Marotta, CarolinaMugeri, DomingoSabbaj, LilianaSoto, AdrianaJosse, ConstantMontestruc, FrancoisMcFarland, Lynne V.BACILLUS CLAUSIIDIARRHEAGASTROENTERITISPROBIOTICSSACCHAROMYCES BOULARDIIhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Background: The choice of an appropriate probiotic for pediatric acute gastroenteritis (PAGE) can be confusing. Our aim was to compare the efficacy and safety of 2 probiotics (Saccharomyces boulardii CNCM I-745 vs a 4-strain mixture of Bacillus clausii O/C, SIN, N/R, T) for the treatment of PAGE. Methods: A 2-arm parallel, randomized trial recruited children (6 months to 5 years old) with mild-moderate acute diarrhea, from 8 centers in Argentina. A total of 317 children were enrolled and blindly randomized to 5 days of either S boulardii CNCM I-745 (n = 159) or a 4-strain mixture of B clausii (n = 158), then followed for 7 days post-probiotic treatment. A stool sample was collected at inclusion for pathogen identification. The primary outcome was duration of diarrhea defined as the time from enrollment to the last loose stool followed by the first 24-hour period with stool consistency improvement. Secondary outcomes included frequency of loose stools/day, severity of diarrhea, number reporting no diarrhea at Day 6, time-to-first formed stool, recurrence of diarrhea by study end (Day 12) and safety outcomes. Results: Three hundred twelve (98%) children completed the study. S boulardii CNCM I-745 showed a significant reduction (P =.04) in the mean duration of diarrhea (64.6 hours, 95% confidence interval [CI] 56.5-72.8) compared to those given B clausii (78.0 hours, 95% CI 69.9-86.1). Both probiotics showed improvement in secondary outcomes and were well-tolerated. Conclusion: In this study, S boulardii CNCM I-745 demonstrated better efficacy than B clausii mix for reducing the duration of pediatric acute diarrhea.Fil: Altcheh, Jaime Marcelo. Gobierno de la Ciudad de Buenos Aires. Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas; ArgentinaFil: Carosella, Mabel V.. No especifíca;Fil: Ceballos, Ana. Instituto Médico Río Cuarto; ArgentinaFil: D'Andrea, Ulises. Instituto Médico Río Cuarto; ArgentinaFil: Jofre, Sandra M.. No especifíca;Fil: Marotta, Carolina. No especifíca;Fil: Mugeri, Domingo. No especifíca;Fil: Sabbaj, Liliana. No especifíca;Fil: Soto, Adriana. No especifíca;Fil: Josse, Constant. No especifíca;Fil: Montestruc, Francois. No especifíca;Fil: McFarland, Lynne V.. No especifíca;Lippincott Williams2022-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/201388Altcheh, Jaime Marcelo; Carosella, Mabel V.; Ceballos, Ana; D'Andrea, Ulises; Jofre, Sandra M.; et al.; Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis; Lippincott Williams; Medicine; 101; 36; 9-2022; 1-80025-7974CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1097/MD.0000000000030500info:eu-repo/semantics/altIdentifier/url/https://journals.lww.com/md-journal/Fulltext/2022/09090/Randomized,_direct_comparison_study_of.31.aspxinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:47:46Zoai:ri.conicet.gov.ar:11336/201388instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:47:46.874CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis |
title |
Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis |
spellingShingle |
Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis Altcheh, Jaime Marcelo BACILLUS CLAUSII DIARRHEA GASTROENTERITIS PROBIOTICS SACCHAROMYCES BOULARDII |
title_short |
Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis |
title_full |
Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis |
title_fullStr |
Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis |
title_full_unstemmed |
Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis |
title_sort |
Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis |
dc.creator.none.fl_str_mv |
Altcheh, Jaime Marcelo Carosella, Mabel V. Ceballos, Ana D'Andrea, Ulises Jofre, Sandra M. Marotta, Carolina Mugeri, Domingo Sabbaj, Liliana Soto, Adriana Josse, Constant Montestruc, Francois McFarland, Lynne V. |
author |
Altcheh, Jaime Marcelo |
author_facet |
Altcheh, Jaime Marcelo Carosella, Mabel V. Ceballos, Ana D'Andrea, Ulises Jofre, Sandra M. Marotta, Carolina Mugeri, Domingo Sabbaj, Liliana Soto, Adriana Josse, Constant Montestruc, Francois McFarland, Lynne V. |
author_role |
author |
author2 |
Carosella, Mabel V. Ceballos, Ana D'Andrea, Ulises Jofre, Sandra M. Marotta, Carolina Mugeri, Domingo Sabbaj, Liliana Soto, Adriana Josse, Constant Montestruc, Francois McFarland, Lynne V. |
author2_role |
author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
BACILLUS CLAUSII DIARRHEA GASTROENTERITIS PROBIOTICS SACCHAROMYCES BOULARDII |
topic |
BACILLUS CLAUSII DIARRHEA GASTROENTERITIS PROBIOTICS SACCHAROMYCES BOULARDII |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Background: The choice of an appropriate probiotic for pediatric acute gastroenteritis (PAGE) can be confusing. Our aim was to compare the efficacy and safety of 2 probiotics (Saccharomyces boulardii CNCM I-745 vs a 4-strain mixture of Bacillus clausii O/C, SIN, N/R, T) for the treatment of PAGE. Methods: A 2-arm parallel, randomized trial recruited children (6 months to 5 years old) with mild-moderate acute diarrhea, from 8 centers in Argentina. A total of 317 children were enrolled and blindly randomized to 5 days of either S boulardii CNCM I-745 (n = 159) or a 4-strain mixture of B clausii (n = 158), then followed for 7 days post-probiotic treatment. A stool sample was collected at inclusion for pathogen identification. The primary outcome was duration of diarrhea defined as the time from enrollment to the last loose stool followed by the first 24-hour period with stool consistency improvement. Secondary outcomes included frequency of loose stools/day, severity of diarrhea, number reporting no diarrhea at Day 6, time-to-first formed stool, recurrence of diarrhea by study end (Day 12) and safety outcomes. Results: Three hundred twelve (98%) children completed the study. S boulardii CNCM I-745 showed a significant reduction (P =.04) in the mean duration of diarrhea (64.6 hours, 95% confidence interval [CI] 56.5-72.8) compared to those given B clausii (78.0 hours, 95% CI 69.9-86.1). Both probiotics showed improvement in secondary outcomes and were well-tolerated. Conclusion: In this study, S boulardii CNCM I-745 demonstrated better efficacy than B clausii mix for reducing the duration of pediatric acute diarrhea. Fil: Altcheh, Jaime Marcelo. Gobierno de la Ciudad de Buenos Aires. Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas; Argentina Fil: Carosella, Mabel V.. No especifíca; Fil: Ceballos, Ana. Instituto Médico Río Cuarto; Argentina Fil: D'Andrea, Ulises. Instituto Médico Río Cuarto; Argentina Fil: Jofre, Sandra M.. No especifíca; Fil: Marotta, Carolina. No especifíca; Fil: Mugeri, Domingo. No especifíca; Fil: Sabbaj, Liliana. No especifíca; Fil: Soto, Adriana. No especifíca; Fil: Josse, Constant. No especifíca; Fil: Montestruc, Francois. No especifíca; Fil: McFarland, Lynne V.. No especifíca; |
description |
Background: The choice of an appropriate probiotic for pediatric acute gastroenteritis (PAGE) can be confusing. Our aim was to compare the efficacy and safety of 2 probiotics (Saccharomyces boulardii CNCM I-745 vs a 4-strain mixture of Bacillus clausii O/C, SIN, N/R, T) for the treatment of PAGE. Methods: A 2-arm parallel, randomized trial recruited children (6 months to 5 years old) with mild-moderate acute diarrhea, from 8 centers in Argentina. A total of 317 children were enrolled and blindly randomized to 5 days of either S boulardii CNCM I-745 (n = 159) or a 4-strain mixture of B clausii (n = 158), then followed for 7 days post-probiotic treatment. A stool sample was collected at inclusion for pathogen identification. The primary outcome was duration of diarrhea defined as the time from enrollment to the last loose stool followed by the first 24-hour period with stool consistency improvement. Secondary outcomes included frequency of loose stools/day, severity of diarrhea, number reporting no diarrhea at Day 6, time-to-first formed stool, recurrence of diarrhea by study end (Day 12) and safety outcomes. Results: Three hundred twelve (98%) children completed the study. S boulardii CNCM I-745 showed a significant reduction (P =.04) in the mean duration of diarrhea (64.6 hours, 95% confidence interval [CI] 56.5-72.8) compared to those given B clausii (78.0 hours, 95% CI 69.9-86.1). Both probiotics showed improvement in secondary outcomes and were well-tolerated. Conclusion: In this study, S boulardii CNCM I-745 demonstrated better efficacy than B clausii mix for reducing the duration of pediatric acute diarrhea. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-09 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/201388 Altcheh, Jaime Marcelo; Carosella, Mabel V.; Ceballos, Ana; D'Andrea, Ulises; Jofre, Sandra M.; et al.; Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis; Lippincott Williams; Medicine; 101; 36; 9-2022; 1-8 0025-7974 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/201388 |
identifier_str_mv |
Altcheh, Jaime Marcelo; Carosella, Mabel V.; Ceballos, Ana; D'Andrea, Ulises; Jofre, Sandra M.; et al.; Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis; Lippincott Williams; Medicine; 101; 36; 9-2022; 1-8 0025-7974 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1097/MD.0000000000030500 info:eu-repo/semantics/altIdentifier/url/https://journals.lww.com/md-journal/Fulltext/2022/09090/Randomized,_direct_comparison_study_of.31.aspx |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Lippincott Williams |
publisher.none.fl_str_mv |
Lippincott Williams |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268880644341760 |
score |
13.13397 |